TruBridge Q1 revenue dips slightly on financial health segment weakness

Trubridge

08/05/2026 21:16

Overview

US healthcare tech provider's Q1 revenue declined slightly year-over-year

Non-GAAP net income rose to $8.5 mln from $5.2 mln in prior year

Company's pending acquisition by IKS Health was previously announced in April

Outlook

Company expects acquisition by IKS Health to close in Q3 2026, pending customary approvals

Result Drivers

SEGMENT PERFORMANCE - Financial Health revenue declined while Patient Care revenue increased, impacting overall results

RECURRING REVENUE - Recurring revenue accounted for 94% of total revenue in the quarter

Company press release: ID:nBw24M71Ra

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 EPS
$0.03
Q1 Net Income
$506,000
Q1 Operating income
$3.06 mln
Q1 Pretax Profit
$582,000


Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

Wall Street's median 12-month price target for TruBridge Inc is $26.25, about 1.8% above its May 7 closing price of $25.78

The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 9 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)